Roy D. Baynes, Director: Travere Therapeutics TVTX Sell · Filed 25/02/10

Trade details

Type: Insider sale
Amount: $220,000
Shares · price: 10,000 sh · $22.00 a share
Held after: 31,000 sh
Stock: Travere Therapeutics TVTX
Person: Roy D. BaynesDirector
Trade date: 25/02/06
Filed: 25/02/10
Days to filing: 4 days

Sold 24.4% of holdings

Share of holding sold: 24.4%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/07~25/03/08

Roy D. Baynes's recent trades

Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/16
Traded 06/12
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/12
Traded 06/12
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/06
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/05
Traded 05/05
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/04
Traded 05/01